ABT Abbott Laboratories PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ABT
- PE Ratio
The current PE ratio for Abbott Laboratories stock as of May 14, 2025 is 16.65. This is calculated based on the current EPS of $7.72 and the stock price of $128.56 per share. The P/E ratio has a decrease of 33% from the past four quarters average of 24.8.
ABT PE ratio history
The average historical PE ratio of Abbott Laboratories for the last ten years is 49.66. The current PE ratio of 16.65 is 66% below the historical average. Over the past ten years, ABT's PE ratio was at its highest in the Mar 2018 quarter at 230.46, when the stock price was $59.92 and the EPS was $0.26. The lowest value was in the Sep 2015 quarter, when it reached 13.27 with a price of $40.22 and an EPS of $3.03.
Abbott Laboratories PE ratio by year
Maximum annual increase: 417.3% in 2017
Maximum annual decrease: -74.46% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 14.75 | -56.05% | $113.11 | $7.67 |
| 2023 | 33.56 | 20.42% | $110.07 | $3.28 |
| 2022 | 27.87 | -21.38% | $109.79 | $3.94 |
| 2021 | 35.45 | -18.41% | $140.74 | $3.97 |
| 2020 | 43.45 | 3.55% | $109.49 | $2.52 |
| 2019 | 41.96 | -22.27% | $86.86 | $2.07 |
| 2018 | 53.98 | -74.46% | $72.33 | $1.34 |
| 2017 | 211.37 | 417.3% | $57.07 | $0.27 |
| 2016 | 40.86 | 167.41% | $38.41 | $0.94 |
| 2015 | 15.28 | -49.08% | $44.91 | $2.94 |
| 2014 | 30.01 | 28.41% | $45.02 | $1.5 |
| 2013 | 23.37 | 34.16% | $38.33 | $1.64 |
| 2012 | 17.42 | -6.14% | $65.5 | $3.76 |
| 2011 | 18.56 | 15.42% | $56.23 | $3.03 |
| 2010 | 16.08 | 10.52% | $47.91 | $2.98 |
Abbott Laboratories PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 17.18 | 16.47% | $132.65 | $7.72 |
| Dec 2024 | 14.75 | -57.31% | $113.11 | $7.67 |
| Sep 2024 | 34.55 | 5.72% | $114.01 | $3.3 |
| Jun 2024 | 32.68 | -7.13% | $103.91 | $3.18 |
| Mar 2024 | 35.19 | 4.86% | $113.66 | $3.23 |
| Dec 2023 | 33.56 | 2.22% | $110.07 | $3.28 |
| Sep 2023 | 32.83 | -11.17% | $96.85 | $2.95 |
| Jun 2023 | 36.96 | 20.82% | $109.02 | $2.95 |
| Mar 2023 | 30.59 | 9.76% | $101.26 | $3.31 |
| Dec 2022 | 27.87 | 28.73% | $109.79 | $3.94 |
| Sep 2022 | 21.65 | -3.73% | $96.76 | $4.47 |
| Jun 2022 | 22.49 | -17.35% | $108.65 | $4.83 |
| Mar 2022 | 27.21 | -23.24% | $118.36 | $4.35 |
| Dec 2021 | 35.45 | 21.82% | $140.74 | $3.97 |
| Sep 2021 | 29.1 | -10.38% | $118.13 | $4.06 |
ABT Price vs fair value
ABT average PE ratio chart
ABT's current P/E ratio is below the 3, 5 and 10-year averages.
ABT PE vs peers
Compared to its peers AZN and TMO, ABT's PE ratio stands lower, however it is higher than JNJ's and NVS's. Abbott Laboratories's PE ratio is trading below the peer group average of 26.46.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFE Pfizer Inc | 15.84 | $125.19B |
| JNJ Johnson & Johnson | 16.15 | $352.15B |
| NVS Novartis AG | 16.3 | $205.71B |
| BMY Bristol Myers Squibb Co | 16.46 | $89.79B |
| ABT Abbott Laboratories | 16.65 | $223.67B |
| HOLX Hologic Inc | 23.16 | $12.34B |
| TMO Thermo Fisher Scientific Inc | 23.76 | $153.28B |
| MDT Medtronic plc | 25.45 | $108.05B |
| AZN Astrazeneca plc | 26.39 | $205.31B |
| BSX Boston Scientific Corp | 74.6 | $152.31B |
Frequently asked questions
What is Abbott Laboratories's PE ratio?
As of May 14, 2025, ABT stock has a price to earnings ratio of 16.65.
What is the 3-year average PE ratio for Abbott Laboratories (ABT)?
The average PE ratio for ABT stock over the past 3 years is 28.36.
What is the 5-year average PE ratio for Abbott Laboratories (ABT)?
The average PE ratio for ABT stock over the past 5 years is 32.75.
What is the highest PE ratio for ABT?
Over the last ten years, the quarterly PE ratio reached a historic high of 230.46 in the Mar 2018 quarter.
How does the current PE ratio for ABT compare to its historical average?
The current price to earnings ratio of ABT is 66% lower than the 10-year historical average.
How is ABT's PE ratio calculated (Abbott Laboratories PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 14, 2025), Abbott Laboratories's stock price is $128.56. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $7.72. Therefore, Abbott Laboratories's P/E ratio for today is 16.65. PE RATIO(16.65) = STOCK PRICE($128.56) / TTM EPS($7.72)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.